UBS identifies stock winners amid structural growth tailwinds

UBS analysts have identified greentech, enabling tech, fintech, and healthtech as key sectors for outperformance via their "Global equity focus list," citing strong structural growth drivers and technological disruption. The firm projects the enabling tech sector to reach $1.2 trillion by 2025 (15% CAGR from FY20-25) and expects investors to benefit from increased tech spending. Key stocks mentioned include Meta, Alibaba, Oracle, Microsoft, Rolls-Royce, Barclays, Euronext, AstraZeneca, Alcon, and Intuitive Surgical, reflecting UBS's focus on companies poised to capitalize on durable, positive structural trends.

Analysis

UBS analysts have identified greentech, enabling tech, fintech, and healthtech as pivotal sectors poised for outperformance, driven by strong structural growth and technological disruption, as outlined in their "Global equity focus list". The enabling technology sector is particularly highlighted, with a projected expansion to USD 1.2 trillion by 2025, representing a 15% compound annual growth rate (CAGR) from FY20-25, suggesting investors may benefit from escalating tech expenditure and robust revenue growth. Key companies in this domain include Meta Platforms (NASDAQ:META), Alibaba (NYSE:BABA), Oracle Corporation (NYSE:ORCL), and Microsoft (NASDAQ:MSFT). Greentech's momentum is underpinned by sustained policy support from major economies aiming for carbon emission reductions and net-zero targets, with Rolls-Royce (OTC:RYCEY) cited as a notable name. Fintech fundamentals are described as strong, buoyed by positive net interest income trends, featuring Barclays (BCS) and Euronext (EPA:ENX) NV in the focus list. Despite recent challenges, the healthtech sector is perceived to have significant catch-up potential, further catalyzed by advancements in generative A.I., with AstraZeneca (NASDAQ:AZN), Alcon (NYSE:ALC), and Intuitive Surgical (NASDAQ:ISRG) among the highlighted firms. Collectively, UBS anticipates these selected stocks will deliver superior earnings growth compared to the broader market, supported by durable, positive structural trends. The overall sentiment surrounding this outlook is strongly positive.

Key Decisions for Investors

• Investors should consider evaluating exposure to the identified themes of greentech, enabling tech, fintech, and healthtech, given UBS's expectation of strong structural growth and market outperformance.
• A thorough due diligence on the specific companies highlighted by UBS, such as META, BABA, MSFT, ORCL, RYCEY, BCS, ENX, AZN, ALC, and ISRG, is warranted to align with individual investment strategies and risk tolerance.
• Monitor key sector-specific catalysts, including ongoing policy developments for greentech, corporate tech spending for enabling tech, interest rate movements and adoption rates for fintech, and AI advancements within healthtech, as these will influence the performance of investments in these areas.